INS and Insulin resistance: Taking into account the possibility of the development of central insulin resistance as a result of prolonged intranasal administration of high-dose insulin, it is important to identify biologically active substances that can enhance the protective effect of insulin and increase its effectiveness at lower doses used for treatment.